Sim1 is a bHLH-PAS transcription factor that is important for neuronal development in the hypothalamus. Loss-of-function mutation of Sim1 causes early onset obesity. However, it is unknown whether and how Sim1 regulates bone remodeling. In this study, we found that adult-onset Sim1 deletion increases bone formation, leading to high bone mass. In contrast, Sim1 over-expressing transgenic mice exhibit decreased bone formation and low bone mass. Sim1 does not directly regulate osteoblastogenesis because bone marrow mesenchymal stem cells from Sim1 mutant mice display a normal capacity for osteoblast differentiation. Instead, Sim1 inhibits bone formation via stimulating the sympathetic nervous system because sympathetic tone is decreased by Sim1 deletion but increased by Sim1 overexpression. Treatment with the ␤-adrenergic agonist isoproterenol effectively reverses the high bone mass in Sim1 KO mice. These findings reveal Sim1 as a critical yet previously unrecognized modulator of skeletal homeostasis that functions through a central relay.
Sim1 is a bHLH-PAS transcription factor that is important for neuronal development in the hypothalamus. Loss-of-function mutation of Sim1 causes early onset obesity. However, it is unknown whether and how Sim1 regulates bone remodeling. In this study, we found that adult-onset Sim1 deletion increases bone formation, leading to high bone mass. In contrast, Sim1 over-expressing transgenic mice exhibit decreased bone formation and low bone mass. Sim1 does not directly regulate osteoblastogenesis because bone marrow mesenchymal stem cells from Sim1 mutant mice display a normal capacity for osteoblast differentiation. Instead, Sim1 inhibits bone formation via stimulating the sympathetic nervous system because sympathetic tone is decreased by Sim1 deletion but increased by Sim1 overexpression. Treatment with the ␤-adrenergic agonist isoproterenol effectively reverses the high bone mass in Sim1 KO mice. These findings reveal Sim1 as a critical yet previously unrecognized modulator of skeletal homeostasis that functions through a central relay.
T
he dynamic bone remodeling is controlled locally in the osseous milieu by osteoblast-mediated bone formation and osteoclast-mediated bone resorption. Imbalance of these two processes can lead to skeletal abnormalities such as osteoporosis, osteosclerosis or osteopetrosis. This skeletal homeostasis is also regulated by endocrine and paracrine factors, including hormones such as parathyroid hormone (PTH) and growth hormone (GH), cytokines such as transformation growth factor-␤ (TGF-␤) and tumor necrosis factor (TNF)-␣ (TNF-␣) (1) . It is also modulated by neuronal mechanisms in the central and peripheral nervous systems (2-4), for example, sympathetic nerve activation of the ␤2-adrenergic receptor (␤2-AR) on osteoblasts suppresses bone formation, and mice lacking ␤2-AR develop high bone mass due to increasing osteogenesis (5) . Interestingly, pharmacologic reduction of sympathetic nervous system tone is emerging as a therapy for patients with osteoporosis (6) .
Single-minded 1 (Sim1) is a transcription factor in the bHLH-PAS (basic helix-loop-helix Per-Arnt-Sim) family that is required for the development of paraventricular (PVN), supraoptic (SON) and anterior periventricular nuclei (aPV) in the hypothalamus (7). Sim1 is highly expressed in the PVN, which sends projections to brainstem and spinal cord sympathetic preganglionic neurons (8) . Haploinsufficiency of SIM1 is associated with severe early-onset obesity in a human girl with a de novo balanced translocation between chromosomes 1p22.1 and 6q16.2 (9) and a Prader-Willi-like phenotype in another case (10) . Heterozygous Sim1-knockout mice also display hyperphagic obesity albeit homozygous Sim1-knockout mice die perinatally (11) , indicating an evolutionarily conserved function of Sim1 in the regulation of obesity.
Although the role of Sim1 in energy metabolism is well recognized, whether Sim1 modulates other physiological functions is unknown. Interestingly, the girl previously reported with a heterozygous SIM1 mutation also had an elevated bone mineral density (BMD) (t-score ϩ2.3 SD, age matched, 67 month) (9) . To determine whether and how Sim1 plays a role in bone mass accrual and skeletal remodeling, here we examined the bone phenotype in Sim1 inducible knockout (Sim1-iKO) mice, which al-lowed us to uncouple the skeletal changes from the early onset obesity that develops in conventional Sim1 heterozygous knockout mice. We found that adult-onset Sim1 deletion augments bone mass and increases bone formation by lowering the sympathetic tone. These findings reveal Sim1 as a key central regulator of bone mass accrual.
Materials and Methods

Mice
Sim1 CamKII-Cre-ERT2 inducible knockout mice have been previously described (12) Mice were fed with standard chow ad libitum and kept on a 12-hour light, 12-hour dark cycle. All experiments were conducted using littermates. For all mice, serum, femurs, tibiae, hypothalamus and interscapular brown adipose tissue (BAT) were collected. Sample size estimate was based on power analyses performed using SAS 9.3 TS X64_7PRO platform at the UTSW Biostatistics Core. With the observed group differences and the relatively small variation of the in vivo measurements, n ϭ 4 and n ϭ 3 will provide Ͼ 90% and Ͼ 80% power at type I error rate of 0.05 (two-sided test), respectively. All protocols for mouse experiments were approved by the Institutional Animal Care and Use Committee of UTSW.
Bone analyses
As previously described (14) 
Ex vivo bone marrow cells differentiation
Osteoblast and osteoclast differentiation from bone marrow cells were performed as previously described (15 
Statistical analyses
Statistical analyses were performed with Student's t-Test and represented as mean Ϯ standard deviation (SD) unless noted otherwise. For three or more groups, statistical analyses were performed by ANOVA and the post hoc Tukey pairwise comparisons. The p values were designated as: *, P Ͻ .05; **, P Ͻ .01; ***, P Ͻ .005; ****, P Ͻ .001; n.s. nonsignificant (P Ͼ .05).
Results
Adult-onset Sim1 deletion causes high bone mass
To investigate the function of Sim1 in adult skeletal remodeling, we examined brain-specific Sim1 inducible knockout (Sim1-iKO) mice that were generated by crossing Sim1 flox mice with calcium/calmodulin-dependent protein kinase II alpha Cre-ERT2 (CamKII-Cre-ERT2) transgenic mice (12) . Tamoxifen was injected into 2-month-old male Sim1 f/f Cre ϩ/-mice to induce adult-onset Sim1 deletion in the brain; as a control, tamoxifen was also injected into 2-month-old male Sim1 f/f Cre -/-littermates. Bone phenotype was compared two months post injection.
Microcomputed tomography (CT) analysis of proximal tibia showed that Sim1-iKO mice developed a high bone mass phenotype compared with the controls. Quantification of bone parameters revealed that KO mice had 1.65-fold higher bone volume/tissue volume ratio (BV/ TV), 1.53-fold higher bone surface (BS), 17% lower bone surface/bone volume ratio (BS/BV), with 1.38-fold higher trabecular number (Tb.N), 1.20-fold higher trabecular thickness (Tb.Th) and 32% lower trabecular separation (Tb.Sp) (Figure 1A-B) . This resulted in a 1.34-fold increase in connectivity density (Conn. D.) ( Figure 1C ) and a 13% decrease in the Structure Model Index (SMI), which quantifies the 3D structure for the relative amount of plates (SMI ϭ 0, strong bone) and rods (SMI ϭ 3, fragile bone) ( Figure 1D) . Moreover, cortical BV/TV and cortical thickness were also increased in Sim1-iKO (Figure S1A-B) . Body weight ( Figure 1E ) and tibia length ( Figure S1C) were not significantly altered in Sim1-iKO mice compared to littermate controls.
ELISA analyses showed that the serum bone formation marker N-terminal propeptide of type I procollagen (P1NP) was increased by 1.45-fold in Sim1-iKO mice (Figure 1F) , whereas the bone resorption marker C-terminal telopeptide fragments of the type I collagen (CTX-1) was unchanged ( Figure 1G) . Consistent with these observations, histomorphometry of the femur showed that bone formation rate and mineral apposition rate (Figure 1H-I) , as well as osteoblast surface and osteoblast number were significantly increased in Sim1-iKO mice (Figure 1J-K) , but osteoclast surface and osteoclast number were unaltered (Figure 1L-M) . A similar but less severe bone phenotype was also observed in male Sim1-iKO mice one month after tamoxifen-induced gene deletion (not shown). Moreover, female Sim1-iKO mice also showed higher bone formation marker and bone mass, although did not quite reach significance; whereas bone resorption marker was also unaltered ( Figure S1D-F) ; Sim1 expression in the hypothalamus was also similar in male mice (0.77 Ϯ 0.28) and female mice (0.68 Ϯ 0.12) (4 months old, n ϭ 6, P ϭ .54). These results suggest that adult-onset Sim1 deletion causes high bone mass primarily through increasing bone formation.
Sim1 overexpression induces bone loss
Complementary to the loss-of-function approach, we next examined the consequences of Sim1 gain-of-function by comparing the human Sim1 BAC transgenic mice (Sim1-Tg) (13) and littermate control mice. Sim1-Tg mice exhibited a low-bone-mass phenotype at 6-month of age (Figure 2 ) but not at 6-week or 2-month of age (not shown), suggesting that longer Sim1 overexpression is required to affect bone potentially due to developmental compensation. CT imaging of proximal tibia showed that Sim1 overexpression induced a significant bone loss, demonstrated by 41% less BV/TV, 58% less BS, 1.17-fold more BS/BV, 32% less Tb.N, 14% less Tb.Th and 1.59-fold greater Tb.Sp (Figure 2A-B) . This resulted in a 35% decrease in Conn. D. (Figure 2C ) and a 1.40-fold increase in SMI (Figure 2D) . Cortical BV/TV, cortical thickness and tibia length were not significantly altered ( Figure  S1G-I) . Chronic Sim1 overexpression also reduced the body weight by 12% in Sim1-Tg mice ( Figure 2E) .
ELISA analyses revealed that Sim1-Tg mice had a 38% decreased P1NP bone formation marker (Figure 2F) , though the CTX-1 bone resorption marker was unchanged ( Figure 2G ). In agreement with these results, histomorphometry showed that Sim1-Tg mice exhibited reduced bone formation rate and mineral apposition rate ( Figure 2H-I) , as well as decreased osteoblast number and osteoblast surface (Figure 2J-K) , but unaltered osteoclast number and osteoclast surface (Figure 2L-M) . Taken together, these results indicate that Sim1 specifically inhibits bone formation without influencing bone resorption.
Sim1 modulates bone formation in a nonbone-cellautonomous manner
To delineate the mechanisms for how Sim1 regulates bone remodeling, we investigated whether Sim1 deletion directly alter bone cell differentiation. Ex vivo osteoblast differentiation from bone marrow cells of Sim1-iKO mice and littermate controls was comparable, demonstrated by the mRNA expression of osteoblasts markers such as Collagen type I, alpha 1 (Col1a1) and osteocalcin, as well as alkaline phosphatase staining of the differentiation cultures (Figure 3A-B) .
Consistent with the unaltered bone resorption and osteoclast number in the Sim1-iKO mice, ex vivo osteoclast differentiation from bone marrow cells of Sim1-iKO mice was also unaltered, shown by the mRNA expression of osteoclast markers such as tartrate resistant acid phos- (Figure 3C-D) . Furthermore, no Sim1 expression was detected in either osteoblast or osteoclast cultures (not shown). These results suggest that Sim1 suppresses bone formation in a nonbone-cell-autonomous manner.
Sim1 inhibits bone formation via enhancing the sympathetic tone
Because Sim1 is mainly expressed in the hypothalamus, we postulated that Sim1 may regulate bone formation, at least in part, via the sympathetic nervous system, which is known to inhibit bone mass accrual (16) . To test this hypothesis, we first analyzed the expression of thermogenesis genes in the brown adipose tissue (BAT), a widely used readout for the sympathetic tone. The results showed that the expression of uncoupling protein 1 (UCP1), type II iodothyronine deiodinase (Dio2) and elongation of very long chain fatty acid-like protein 3 (ELOVL3) in BAT was significantly decreased in Sim1-iKO mice (Figure 4A ), but significantly increased in Sim1-Tg mice ( Figure 4B ). These findings suggest that Sim1 enhances the sympathetic activity in the nervous system.
To investigate whether Sim1 stimulation of the sympathetic tone is required for Sim1 inhibition of bone formation, we treated Sim1-iKO mice or littermate controls with isoproterenol, a nonselective ␤-adrenergic agonist, for four weeks. Isoproterenol treatment increased BAT gene expression in Sim1-iKO mice to a similar level as in control mice, indicating an effective rescue of the sympathetic tone ( Figure 4C) . As a result, isoproterenol treatment completely abolished the increased bone formation in Sim1-iKO mice (Figure 4D ), leading to a significant rescue of the high-bone-mass phenotype ( Figure 4E) . This was further demonstrated by the complete rescue of the high bone formation rate and mineral apposition rate (Figure 4F) , as well as osteoblast surface and osteoblast number ( Figure  4G ) in the Sim1-iKO mice by isoproterenol treatment. Together, these findings indicate that Sim1 suppresses bone formation by enhancing the sympathetic tone ( Figure 4H) .
Discussion
Sim1 is known to be involved in brain development and energy homeostasis (7, 9, 17, 18) . In this study, using both loss-and gain-of-function analyses, we reveal a critical yet previously unrecognized function of Sim1 in bone remodeling. Adult-onset Sim1 deletion in the brain causes a high bone mass due to increased bone formation, whereas Sim1 overexpression causes a low bone mass due to decreased bone formation. Mechanistically, Sim1 inhibits bone formation by enhancing the sympathetic nervous system. These findings identify Sim1 as a novel central regulator of bone mass accrual, and a crucial player in the intricate neuroendocrine network that governs skeletal homeostasis.
Several neuropeptides have been reported to regulate both bone mass and obesity, such as neuropeptide Y (NPY), neuromedin U (NMU) and our recently described orexin (19 -24 We delineate that Sim1 suppresses bone formation in a nonbone-cell-autonomous manner by mainly enhancing the sympathetic tone in the nervous system independent of the obesity phenotype. Oxytocin is one of the most important downstream targets of Sim1 (7, 25) . Sim1 deficient mice have lower oxytocin levels, and central oxytocin injection rescues the hyperphagic obesity in Sim1 KO mice (26) . It has been shown that oxytocin-deficient mice exhibit a decreased sympathetic tone (27) . In light of the well-known role of the sympathetic nerves in suppressing bone formation (28, 29) , we have tested the hypothesis that Sim1 regulation of bone mass accrual was mediated by the sympathetic nervous system. Indeed, sympathetic tone is lower in Sim1-iKO mice but higher in Sim1-Tg mice. Reactivation of the sympathetic tone by isoproterenol, a ␤-adrenergic agonist, completely abolishes the excessive bone formation in the Sim1-iKO mice and significantly rescues their high bone mass phenotype. Taken together, these findings support a working model that Sim1 inhibits bone formation via a brain-sympathetic nerve-bone central relay. . Ucp1, uncoupling protein 1; Dio2, deiodinase, iodothyronine, type II; Elovl3, elongation of very long chain fatty acids protein 3. A, Comparison between Sim1-iKO mice and littermate controls (n ϭ 6, male, 2 months post tamoxifen injection, 4-month-old at end point). B, Comparison between Sim1-Tg mice and littermate controls (n ϭ 6, male, 6-month-old). C-G, Isoproterenol treatment rescues sympathetic tone and bone phenotype in Sim1-iKO mice. Sim1-iKO mice and littermate controls (n ϭ 6, male, 2 months post tamoxifen injection, 4-month-old at end point) were treated with isoproterenol (5 mg/kg/d) or vehicle control daily for the last four weeks. C, Expression of sympathetic output marker genes in interscapular BAT. The results are shown as fold changes for Sim1-iKO/Ctrl; * and n.s. compare Sim1-iKO and controls in each treatment group (n ϭ 6). D, Serum P1NP bone formation marker (n ϭ 6). E, BV/TV in proximal tibiae by CT (n ϭ 6). F, Bone formation rate (BFR) and mineral apposition rate (MAR) (n ϭ 6). G, Osteoblast surface (Oc.S/B.S) and osteoblast number (Oc.N/B.S) (n ϭ 6); B.S, bone surface. H, A schematic diagram of a simplified model for how Sim1 in the brain inhibits bone formation by enhancing the sympathetic nervous system (SNS 
